Glendale Adventist Medical Center

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Bladder cancer1 trial
• Cervical cancer1 trial
• Colorectal cancer1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial
• Melanoma1 trial
• Multiple sclerosis1 trial
• Prostate cancer1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Active, not recruiting4 trials
• Completed1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• ImmunityBio, Inc.1 trial
• Novartis Pharmaceuticals1 trial
• Pfizer1 trial

Running trials

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

  NCT05147220· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

  NCT03228667· Phase 2· ImmunityBio, Inc.· Source

• Active, not recruiting

  Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC

  NCT03395197· Phase 3· Pfizer· Source

Closed trials

• Recruiting

  A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT06667076· Phase 2· Janssen Research & Development, LLC· Source